Cardiovascular impact of near complete estrogen deprivation in premenopausal women with breast cancer: The CROWN study.
Thomas A, O'Connell NS, Douglas E, Hatcher S, Park CJ, Dent S, Ansley K, Klem I, Bansal R, Westbrook K, Hundley WG, Bottinor W, Hackney MH, Richardson KM, Sirkisoon SR, D'Agostino RB Jr, Jordan JH.
Thomas A, et al. Among authors: jordan jh.
Am Heart J. 2024 Jan;267:33-43. doi: 10.1016/j.ahj.2023.10.007. Epub 2023 Oct 26.
Am Heart J. 2024.
PMID: 37890547
Ovarian function suppression paired with aromatase inhibition, for premenopausal women with hormone receptor (HR)-positive breast cancer, is a newer widely adopted therapy with the potential for significant long-term cardiovascular toxicity. Abrupt estrogen deprivation for …
Ovarian function suppression paired with aromatase inhibition, for premenopausal women with hormone receptor (HR)-positive breast cancer, is …